scispace - formally typeset
Journal ArticleDOI

L-tryptophan-associated eosinophilia-myalgia syndrome: Clinical and pathological features of an evolving new disease and current concepts of etiology

John Varga
- 01 Sep 1993 - 
- Vol. 8, Iss: 5, pp 229-242
Reads0
Chats0
TLDR
Experimental studies suggest a major role for eosinophil and fibroblast activation in the pathogenesis of EMS, and a recently identified second contaminant is chemically similar to analide derivatives isolated from samples of cooking oils that caused the toxic oil epidemic in Spain.
Abstract
The eosinophilia-myalgia syndrome (ENS) is a newly recognized illness that occurred in the United States and in other countries in an'epidemic form during 1989. The outbreak was associated with ingestion of the essentid amino acid Ltryptophan. The illness appears to be heterogeneous; it has an early phase characterized by myalgia, skin rashes, constitutional symptoms, and marked peripheral blood eosinophilia, f o l l o n d by a late phase characterized by chronic cutaneous, neuromusculx, pulmonary, and other manifestations. Because EMS has no pathognomonic findings, the diagnosis is based on recognizing the characteristic clinical and laboratory features of the syndrome, supported by the histopathological findings of inflammation and fibrosis of the subcutaneous fascia and the connective tissue structures surrounding skeletal muscle and peripheral nerve fibers. Toxicoepidemiological studies suggest that the epidemic of EXIS was caused by a point-source contamination of Ltryptophan preparations. Analysis of L-tryptophan preparations identified a tryptophan-related novel amino acid present only in batches associated n-ith EMS. but extensive studies with animals have thus far failed to establish an etiologic role for this contaminant in EXIS. A recently identified second contaminant is chemically similar to analide derivatives isolated from samples of cooking oils that caused the toxic oil epidemic in Spain. Experimental studies suggest a major role for eosinophil and fibroblast activation in the pathogenesis of EMS. This newly recognized illness has focused intense interest on the role of chemical and environmental agents in the pathogenesis of various idiopathic illnesses characterized by inflammation and fibrosis.

read more

Citations
More filters

smallcap˜L-tryptophan and eosinophilia-myalgia syndrome in New Mexico.

TL;DR: In 1989, the New Mexico Health and Environment Department learned of 3 patients with eosinophilia and severe myalgia who had been taking L-tryptophan and further review of these and similar cases led to the initial recognition of the EOSINophilia-myalgia syndrome (EMS) epidemic.
References
More filters
Journal ArticleDOI

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

TL;DR: Further data are obtained to support a role for TGF-beta as an intrinsic mediator of collagen formation: conditioned media obtained from activated human tonsillar T lymphocytes contain greatly elevated levels of T GF-beta compared tomedia obtained from unactivated lymphocytes.
Journal ArticleDOI

NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

TL;DR: Chemotherapy to lower the eosinophil counts has resulted in marked improvement of HES prognosis, as have agressive medical and surgical approaches to cardiovascular complications.
Journal ArticleDOI

The immunobiology of eosinophils.

TL;DR: Tinctorial properties remain the routine basis for identifying and enumerating these leukocytes in blood and tissues, and eosinophilia, characterized by both heightened production of eosInophils in bone marrow and the accumulation of eOSinophils, is characterized.
Journal Article

Cytotoxic Properties of the Eosinophil Major Basic Protein

TL;DR: The hypothesis that the eosinophil produces damage to cells in disease is suggested after concentrations of MBP in the toxic range were found in sputa from asthmatics, in pleural fluid and in sera.